High blood pressure, also called hypertension, affects millions of people worldwide and is one of the biggest risk factors for heart attacks, strokes, heart failure, and kidney disease.
Many people need daily medicine to keep their blood pressure under control because lifestyle changes alone are not always enough. Choosing the safest and most effective medicine is an important part of long-term treatment.
Two of the most commonly prescribed medicines for high blood pressure are chlorthalidone and hydrochlorothiazide. Both belong to a group of medicines called thiazide diuretics, often known as water tablets. They lower blood pressure by helping the body remove extra salt and water through urine, reducing the workload on the heart.
A large new study has compared these two medicines to find out whether one is safer than the other. The research was led by Dr. George Hripcsak at Columbia University and was published in the journal JAMA Internal Medicine. It followed more than 730,000 people over a period of 17 years, making it one of the largest studies ever conducted on these medicines.
The researchers found that both drugs worked equally well at lowering blood pressure and preventing major cardiovascular problems, including heart attacks, strokes, and heart failure. However, they also discovered important differences in safety. People taking chlorthalidone experienced significantly more side effects than those taking hydrochlorothiazide.
The biggest concern was a condition called hypokalemia, which means potassium levels in the blood become too low. Potassium is a mineral that helps the heart, muscles, and nerves work properly. If potassium drops too far, it can lead to irregular heartbeats, muscle weakness, confusion, kidney problems, and may even increase the risk of developing type 2 diabetes.
The study found that 6.3% of people taking chlorthalidone developed hypokalemia, compared with only 1.9% of those taking hydrochlorothiazide. In other words, patients taking chlorthalidone were about three times more likely to develop this potentially serious problem.
They also had a higher risk of other electrolyte imbalances and kidney complications, even when taking lower doses.
These findings have prompted experts to reconsider whether chlorthalidone should continue to be recommended as a first-choice treatment for many patients with high blood pressure. Doctors may decide to monitor potassium levels and kidney function more closely in people taking this medicine. In some cases, another blood pressure medicine may be a better option.
Despite these findings, people should not stop taking their prescribed medicine without first speaking to their doctor. High blood pressure itself is a serious condition that often has no symptoms until major damage has already occurred. Stopping treatment suddenly could greatly increase the risk of heart attack, stroke, and other complications.
Medicine is only one part of controlling blood pressure. Eating a healthy diet, limiting salt, staying physically active, maintaining a healthy weight, reducing alcohol, avoiding smoking, managing stress, and checking blood pressure regularly at home can all help improve long-term health. These habits work together with medication to reduce cardiovascular risk.
This study highlights the growing importance of personalized medical care. Although both medicines lower blood pressure effectively, they do not affect everyone in the same way.
By considering both the benefits and the possible side effects of each treatment, doctors can choose the medicine that best suits each patient’s health needs while improving both safety and long-term outcomes.
If you care about high blood pressure, please read studies about breakfast for better blood pressure management, and the gut feeling that lowers blood pressure.
For more health information, please see recent studies about how the dash diet helps lower blood pressure, and how to eat your way to healthy blood pressure.
Copyright © 2026 Knowridge Science Report. All rights reserved.
